Search Results - "Burcelin, Remy"

Refine Results
  1. 1

    Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice by Membrez, Mathieu, Blancher, Florence, Jaquet, Muriel, Bibiloni, Rodrigo, Cani, Patrice D., Burcelin, Rèmy G., Corthesy, Irene, Macé, Katherine, Chou, Chieh Jason

    Published in The FASEB journal (01-07-2008)
    “…ABSTRACT Recent data suggest that the gut microbiota plays a significant role in fat accumulation. However, it is not clear whether gut microbiota is involved…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Host-Gut Microbiota Metabolic Interactions by Nicholson, Jeremy K., Holmes, Elaine, Kinross, James, Burcelin, Remy, Gibson, Glenn, Jia, Wei, Pettersson, Sven

    “…The composition and activity of the gut microbiota codevelop with the host from birth and is subject to a complex interplay that depends on the host genome,…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Shaping the Gut Microbiota by Breastfeeding: The Gateway to Allergy Prevention? by van den Elsen, Lieke W J, Garssen, Johan, Burcelin, Remy, Verhasselt, Valerie

    Published in Frontiers in pediatrics (27-02-2019)
    “…Evidence is accumulating that demonstrates the importance of the gut microbiota in health and diseases such as allergy. Recent studies emphasize the importance…”
    Get full text
    Journal Article
  6. 6

    GLP-1, the gut-brain, and brain-periphery axes by Cabou, Cendrine, Burcelin, Rémy

    Published in The review of diabetic studies (2011)
    “…Glucagon-like peptide 1 (GLP-1) is a gut hormone which directly binds to the GLP-1 receptor located at the surface of the pancreatic β-cells to enhance…”
    Get full text
    Journal Article
  7. 7

    Neuroprotective properties of GLP-1: theoretical and practical applications by Holst, Jens Juul, Burcelin, Remy, Nathanson, Esther

    Published in Current medical research and opinion (01-03-2011)
    “…Abstract In the past few years, the development of pharmaceutical agents that enhance the physiological effects of glucagon-like peptide-1 (GLP-1), either…”
    Get full text
    Journal Article
  8. 8

    Oral Microbiota: A Major Player in the Diagnosis of Systemic Diseases by Thomas, Charlotte, Minty, Matthieu, Vinel, Alexia, Canceill, Thibault, Loubières, Pascale, Burcelin, Remy, Kaddech, Myriam, Blasco-Baque, Vincent, Laurencin-Dalicieux, Sara

    Published in Diagnostics (Basel) (30-07-2021)
    “…The oral cavity is host to a complex and diverse microbiota community which plays an important role in health and disease. Major oral infections, i.e., caries…”
    Get full text
    Journal Article
  9. 9

    Therapeutic modulation of microbiota-host metabolic interactions by Holmes, Elaine, Kinross, James, Gibson, Glenn R, Burcelin, Remy, Jia, Wei, Pettersson, Sven, Nicholson, Jeremy K

    Published in Science translational medicine (06-06-2012)
    “…The complex metabolic relationships between the host and its microbiota change throughout life and vary extensively between individuals, affecting disease risk…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12

    Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase by DUPLAIN, Hervé, BURCELIN, Rémy, SCHERRER, Urs, SARTORI, Claudio, COOK, Stéphane, EGLI, Marc, LEPORI, Mattia, VOLLENWEIDER, Peter, PEDRAZZINI, Thierry, NICOD, Pascal, THORENS, Bernard

    Published in Circulation (New York, N.Y.) (17-07-2001)
    “…Insulin resistance and arterial hypertension are related, but the underlying mechanism is unknown. Endothelial nitric oxide synthase (eNOS) is expressed in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Gut microbiota and immune crosstalk in metabolic disease by Burcelin, Rémy

    Published in Molecular metabolism (Germany) (01-09-2016)
    “…Abstract Background Gut microbiota is considered as a major regulator of metabolic disease. This reconciles the notion of metabolic inflammation and the…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Evaluation of Glucose and Lipid Lowering Activity of Arganimide A in Normal and Streptozotocin-Induced Diabetic Rats by Eddouks, Mohamed, Khallouki, Farid, Owen, Robert W, Hebi, Morad, Burcelin, Remy

    “…Arganimide A (4,4-dihydroxy-3,3-imino-di-benzoic acid) is a compound belonging to a family of aminophenolics found in fruit of Argania spinosa. The purpose of…”
    Get more information
    Journal Article
  20. 20

    Intestinal MicrobiOMICS to define health and disease in human and mice by Serino, Matteo, Chabo, Chantal, Burcelin, Remy

    Published in Current pharmaceutical biotechnology (01-04-2012)
    “…Over the last five years an increasing effort has been made to understand the role of intestinal microbiota in health and disease, resulting in regarding to it…”
    Get more information
    Journal Article